InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,303.27
(
0.12%
)
US TECH 100
18,065.60
(
-0.08%
)
Dow Jones
40,003.59
(
0.34%
)
Brent Oil
83.76
(
0.67%
)
Bitcoin
66,792.95
(
2.38%
)
Post# of 251852
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119659
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: iwfal post# 135728

Tuesday, 04/07/2015 11:23:08 AM

Tuesday, April 07, 2015 11:23:08 AM

Post# of 251852
New item for the biotech newbie list (an elaboration of item #13)….

If a former executive from another biotech company had a track record of bringing products to market at his/her old company, the track record is certain to carry over to the company where he/she currently works, ensuring both regulatory and commercial success of all products in the pipeline.

(See #msg-112463455.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up